Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in Shb-Deficient Endothelial Cells Increases Tumor Lung Metastasis
Open Access
- 25 October 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11478
Abstract
Metastasis reflects both the inherent properties of tumor cells and the response of the stroma to the presence of the tumor. Vascular barrier properties, either due to endothelial cell (EC) or pericyte function, play an important role in metastasis in addition to the contribution of the immune system. The Shb gene encodes the Src homology-2 domain protein B that operates downstream of tyrosine kinases in both vascular and immune cells. We have investigated E0771.lmb breast carcinoma metastasis in mice with conditional deletion of the Shb gene using the Cdh5-CreERt2 transgene, resulting in inactivation of the Shb-gene in EC and some hematopoietic cell populations. Lung metastasis from orthotopic tumors, tumor vascular and immune cell characteristics, and immune cell gene expression profiles were determined. We found no increase in vascular leakage that could explain the observed increase in metastasis upon the loss of Shb expression. Instead, Shb deficiency in EC promoted the recruitment of monocytic/macrophagic myeloid-derived suppressor cells (mMDSC), an immune cell type that confers a suppressive immune response, thus enhancing lung metastasis. An MDSC-promoting cytokine/chemokine profile was simultaneously observed in tumors grown in mice with EC-specific Shb deficiency, providing an explanation for the expanded mMDSC population. The results demonstrate an intricate interplay between tumor EC and immune cells that pivots between pro-tumoral and anti-tumoral properties, depending on relevant genetic and/or environmental factors operating in the microenvironment.Keywords
Funding Information
- Cancerfonden (2018/287)
This publication has 40 references indexed in Scilit:
- Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiencyAngiogenesis, 2012
- Heterogeneity among RIP‐Tag2 insulinomas allows vascular endothelial growth factor‐A independent tumor expansion as revealed by studies in Shb mutant mice: Implications for tumor angiogenesisMolecular Oncology, 2012
- VEGF-Induced Vascular Permeability Is Mediated by FAKDevelopmental Cell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cellsBMC Immunology, 2011
- DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteriesBlood, 2009
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor AngiogenesisCancer Cell, 2009
- Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor GrowthCancer Research, 2009
- Pericytes limit tumor cell metastasisJournal of Clinical Investigation, 2006
- vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineagesGenesis, 2002